James Maryanski
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (February 2009) |
James Maryanski (born ) is the Biotechnology Coordinator for the Food and Drug Administration's Center for Food Safety and Applied Nutrition. He began working for the FDA in 1977 and became acting Coordinator for biotechnology policy in 1986.
Education
Maryanski received a BSc in microbiology from Ohio State University, in 1965 after which he was briefly employed by the US Public Health Service in Ohio. Maryanski received a PhD in 1972 from the University of New Hampshire where he had studied microbiology, molecular biology, and marine science.
He then spent four years at the National Institute for Dental Research, of the National Institutes of Health, investigating carbohydrate transport and cell adhesion in dental micro-organisms. Dr Maryanski regularly serves as an expert consultant on food biotechnology representing the FDA in varying capacities.
Controversial FDA Career
Maryanski travels the world promoting the safety of GM crops. [1] He has supported the safety of Calgene's Flavr Savr tomato and the principle that GM crops are safe until found to be harmful. This position has been criticized for using the public as guinea pigs in the testing of GM food safety[2].
Maryanski is the first FDA name on the biotechnology consultation, done for Monsanto Company's Roundup Ready Soy.
Awards
He has received the FDA Commissioner's Special Citation and Commendable Service Awards for his work in food biotechnology.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
1999 testimony on GMO safety
